The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study to determine the safety and efficacy of onvansertib, a novel, oral, PLK1 inhibitor in patients with proliferative chronic myelomonocytic leukemia relapsed/refractory or intolerant to available therapies.
 
Kristen McCullough
No Relationships to Disclose
 
Abhishek A Mangaonkar
Research Funding - BMS (Inst)
 
Ashya R. Burgess
No Relationships to Disclose
 
Aref Al-Kali
Research Funding - Ambit BioSciences (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); H3 Biomedicine (Inst); MedImmune (Inst); Novartis (Inst); Onconova Therapeutics (Inst)
 
Hassan B. Alkhateeb
No Relationships to Disclose
 
Kebede Begna
Consulting or Advisory Role - Novartis/Pfizer
 
Naseema Gangat
No Relationships to Disclose
 
Susan Michelle Geyer
Research Funding - Brisol-Myers-Squibb (Inst); Celgene (Inst); Johnson & Johnson/Janssen (Inst)
 
William J. Hogan
No Relationships to Disclose
 
Mark Robert Litzow
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Abbvie; Actinium Pharmaceuticals; Amgen; Astellas Pharma; Novartis; Pluristem Therapeutics; Syndax
Other Relationship - Biosight
 
Kaaren Reichard
Honoraria - American Society for Clinical Pathology; Elsevier
Consulting or Advisory Role - E-Squared Communications
 
Antoine N Saliba
No Relationships to Disclose
 
Mithun Vinod Shah
Research Funding - Archer
 
Alexandra P. Wolanskyj-Spinner
No Relationships to Disclose
 
Mrinal Mahesh Patnaik
Consulting or Advisory Role - CTI BioPharma Corp
Research Funding - Kura Oncology (Inst); Stemline Therapeutics (Inst)